REQUEST A DEMO
Total
USD $0.00
Search more companies

Boolim Pharm Co.,Ltd. (Gimpo) (South Korea)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Boolim Pharm Co.,Ltd. Profile Updated: October 23, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Boolim Pharm Co.,Ltd. (Gimpo) is an enterprise based in South Korea. Its main office is in Gimpo. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on October 15, 1985. There are currently 59 (2023) people employed by Boolim Pharm Co.,Ltd. (Gimpo). In its most recent financial highlights, the company reported a net sales revenue increase of 6.19% in 2022. Its’ total assets recorded a growth of 9.93%.

Headquarters
4-dong, 35-21, Arayuk-ro 58beon-gil Gochon-eup Gimpo-si Gyeonggi
Gimpo; Gyeonggi;

Contact Details: Purchase the Boolim Pharm Co.,Ltd. (Gimpo) report to view the information.

Basic Information
Total Employees:
Purchase the Boolim Pharm Co.,Ltd. (Gimpo) report to view the information.
Outstanding Shares:
Purchase the Boolim Pharm Co.,Ltd. (Gimpo) report to view the information.
Registered Capital:
Purchase the Boolim Pharm Co.,Ltd. (Gimpo) report to view the information.
Incorporation Date:
October 15, 1985
Key Executives
Purchase this report to view the information.
Chairman
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Bulim Co.,Ltd.
Company Performance
Financial values in the chart are available after Boolim Pharm Co.,Ltd. (Gimpo) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
6.19%
Total operating revenue
6.19%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
9.93%
Total equity
-11.38%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
-0.08%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?